Annual report [Section 13 and 15(d), not S-K Item 405]

Assets and Liabilities Measured at Fair Value (Tables)

v3.25.4
Assets and Liabilities Measured at Fair Value (Tables)
12 Months Ended
Dec. 31, 2025
Assets and Liabilities Measured at Fair Value  
Schedule of assets and liabilities measured at fair value

December 31, 2025

December 31, 2024

 

  ​ ​ ​

  ​ ​ ​

Quoted prices

  ​ ​ ​

Significant other

  ​ ​ ​

  ​ ​ ​

Quoted prices

  ​ ​ ​

Significant other

 

in active markets

observable

in active markets

observable

 

for identical assets

inputs

for identical assets

inputs

 

Total

(Level 1)

(Level 2)

Total

(Level 1)

(Level 2)

 

amounts in millions

 

Cash equivalents

  ​ ​ ​

$

783

  ​ ​ ​

783

  ​ ​ ​

  ​ ​ ​

2,142

  ​ ​ ​

2,142

  ​ ​ ​

  ​

Financial instrument assets

$

122

  ​ ​ ​

109

  ​ ​ ​

13

 

167

  ​ ​ ​

84

  ​ ​ ​

83

Debt

$

597

  ​ ​ ​

  ​ ​ ​

597

 

588

  ​ ​ ​

  ​ ​ ​

588

Financial instrument liabilities

$

138

138

Schedule of realized and unrealized gains (losses) on financial instruments

Realized and unrealized gains (losses) on financial instruments, net are comprised of changes in the fair value of the following (amounts in millions):

Years ended December 31,

 

  ​ ​ ​

2025

  ​ ​ ​

2024

  ​ ​ ​

2023

 

Debt measured at fair value (a)

$

(6)

 

(95)

 

(13)

Foreign currency forward contracts

335

(138)

Interest rate swaps

(41)

103

28

Debt and equity securities

(12)

 

(5)

 

27

Other

 

12

 

(4)

 

2

$

288

 

(139)

 

44

(a) The Company elected to account for its convertible notes (as described in note 8) using the fair value option. Changes in the fair value of the convertible notes recognized in the consolidated statements of operations are primarily due to market factors primarily driven by changes in the fair value of the underlying shares into which the debt is exchangeable. The Company isolates the portion of the unrealized gain (loss) attributable to changes in the instrument specific credit risk and recognizes such amount in other comprehensive earnings (loss). The change in the fair value
of the convertible notes attributable to changes in the instrument specific credit risk was a loss of $4 million, loss of $15 million and loss of $12 million for the years ended December 31, 2025, 2024 and 2023, respectively. The cumulative change since issuance was a gain of $65 million as of December 31, 2025, net of the recognition of previously unrecognized gains and losses.